Kathleen Cohen
InvestorSenior Vice President, Clinical Development Operations at Avalo Therapeutics
About
Over 25 years of clinical research and development experience. Previously held leadership roles in small biotech overseeing clinical development and program management across cross-functional teams. Spent over two decades at a leading global CRO in various project management and operational positions, including leading the program for the first FDA-approved angiogenesis-targeting therapy.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Gilla Kaplan
Board Member at Avalo Therapeutics
Jennifer Riley
Chief Strategy Officer at Avalo Therapeutics